Agilent Technologies ROE 2006-2018 | A
Current and historical return on equity (ROE) values for Agilent Technologies (A) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Agilent Technologies ROE for the three months ending July 31, 2018 was 18.61%.
| Agilent Technologies ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2018-07-31 |
$0.30B |
$4.57B |
6.43% |
| 2018-04-30 |
$0.24B |
$4.62B |
5.10% |
| 2018-01-31 |
$0.20B |
$4.53B |
4.27% |
| 2017-10-31 |
$0.68B |
$4.84B |
15.10% |
| 2017-07-31 |
$0.63B |
$4.61B |
14.44% |
| 2017-04-30 |
$0.58B |
$4.38B |
13.48% |
| 2017-01-31 |
$0.51B |
$4.30B |
11.94% |
| 2016-10-31 |
$0.46B |
$4.25B |
11.00% |
| 2016-07-31 |
$0.48B |
$4.35B |
11.38% |
| 2016-04-30 |
$0.46B |
$4.17B |
11.23% |
| 2016-01-31 |
$0.46B |
$4.05B |
11.14% |
| 2015-10-31 |
$0.40B |
$4.17B |
9.62% |
| 2015-07-31 |
$0.28B |
$4.11B |
6.22% |
| 2015-04-30 |
$0.31B |
$4.16B |
6.47% |
| 2015-01-31 |
$0.37B |
$4.24B |
7.01% |
| 2014-10-31 |
$0.50B |
$5.30B |
9.03% |
| 2014-07-31 |
$0.69B |
$5.64B |
12.58% |
| 2014-04-30 |
$0.71B |
$5.63B |
13.48% |
| 2014-01-31 |
$0.74B |
$5.45B |
14.21% |
| 2013-10-31 |
$0.72B |
$5.29B |
13.96% |
| 2013-07-31 |
$0.94B |
$4.79B |
18.18% |
| 2013-04-30 |
$1.01B |
$5.31B |
19.56% |
| 2013-01-31 |
$1.10B |
$5.35B |
21.89% |
| 2012-10-31 |
$1.15B |
$5.19B |
23.92% |
| 2012-07-31 |
$1.02B |
$4.87B |
22.09% |
| 2012-04-30 |
$1.10B |
$4.73B |
24.89% |
| 2012-01-31 |
$1.05B |
$4.50B |
24.72% |
| 2011-10-31 |
$1.01B |
$4.32B |
25.59% |
| 2011-07-31 |
$1.02B |
$4.20B |
27.55% |
| 2011-04-30 |
$0.89B |
$3.96B |
26.67% |
| 2011-01-31 |
$0.80B |
$3.34B |
26.56% |
| 2010-10-31 |
$0.68B |
$3.24B |
24.26% |
| 2010-07-31 |
$0.42B |
$2.81B |
15.80% |
| 2010-04-30 |
$0.19B |
$2.63B |
7.54% |
| 2010-01-31 |
$-0.02B |
$2.60B |
-0.64% |
| 2009-10-31 |
$-0.03B |
$2.51B |
-1.24% |
| 2009-07-31 |
$0.18B |
$2.49B |
6.97% |
| 2009-04-30 |
$0.36B |
$2.42B |
13.53% |
| 2009-01-31 |
$0.64B |
$2.57B |
22.21% |
| 2008-10-31 |
$0.69B |
$2.56B |
22.96% |
| 2008-07-31 |
$0.64B |
$3.19B |
20.14% |
| 2008-04-30 |
$0.66B |
$3.16B |
20.48% |
| 2008-01-31 |
$0.61B |
$3.17B |
18.35% |
| 2007-10-31 |
$0.64B |
$3.23B |
18.58% |
| 2007-07-31 |
$0.61B |
$3.29B |
17.16% |
| 2007-04-30 |
$0.65B |
$3.56B |
17.72% |
| 2007-01-31 |
$0.64B |
$3.66B |
16.90% |
| 2006-10-31 |
$3.31B |
$3.65B |
84.28% |
| 2006-07-31 |
$3.18B |
$3.79B |
78.94% |
| 2006-04-30 |
$3.06B |
$4.07B |
75.16% |
| 2006-01-31 |
$3.04B |
$4.18B |
75.62% |
| 2005-10-31 |
$0.33B |
$4.08B |
8.35% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Electrical Test Equipment |
$20.232B |
$4.472B |
|
Agilent Technologies Inc. focuses its expertise on six key markets: Food; Environmental and Forensics; Pharmaceutical; Diagnostics; Chemical and Energy; and Research. Agilent helps ensure that their global food supply is free of contaminants, whether chemical, viral, bacterial or microbiological. The Company's customers include government regulators and labs that control food safety, as well as private companies that produce, package and sell food to the public. Agilent has one of the broadest solutions portfolios of any company serving the pharmaceutical industry. Its solutions provide precise answers for every segment of the pharmaceutical industry, from disease research and drug discovery to drug development, manufacturing and quality control. Agilent gives doctors a head start in the fight against cancer and other diseases. Agilent's immunohistochemistry (IHC) products provide high staining quality, improved standardization and increased efficiency enabling the ultimate goal of increased patient safety.
|
